IC B Complex Injectable Recalled for Lack of Sterility Assurance
Talon Compounding Pharmacy is recalling IC B Complex Injectable due to lack of assurance of sterility. The affected vial lot 09152021:12 was distributed across the United States, Washington, D.C., and Puerto Rico.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a compounded injectable pharmaceutical product with loss of sterility assurance, which is a high-risk hazard for injection-route drugs. The source states FDA Class II classification. Although no illnesses or injuries are explicitly reported in the source, the potential for serious harm (infection, sepsis) from non-sterile injectables meets the criteria for a High severity rating.
Plain-English summary
Vita Pharmacy, LLC, doing business as Talon Compounding Pharmacy, is recalling IC B Complex Injectable (Rx only) due to lack of assurance of sterility. The product is a compounded injectable solution distributed in single vials.
The recalled product was lot 09152021:12 with a beyond-use date of 12/14/2021, distributed throughout the United States, including Washington, D.C., and Puerto Rico. The compounding pharmacy is located at 2950 Thousand Oaks Drive Suite 25, San Antonio, Texas 78247.
Consumers and healthcare providers should not use this product. Persons who may have received this medication should contact their healthcare provider or pharmacist for guidance. The lack of sterility assurance in injectable products presents a potential health risk, as sterile conditions are critical for injectables to prevent infection and other complications.
The recalled product
- Product
- IC B COMPLEX INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 09152021:12 BUD: 12/14/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27